| First Author | Wu J | Year | 2020 |
| Journal | J Invest Dermatol | Volume | 140 |
| Issue | 2 | Pages | 465-476.e11 |
| PubMed ID | 31376385 | Mgi Jnum | J:284290 |
| Mgi Id | MGI:6387577 | Doi | 10.1016/j.jid.2019.07.694 |
| Citation | Wu J, et al. (2020) MicroRNA-34 Family Enhances Wound Inflammation by Targeting LGR4. J Invest Dermatol 140(2):465-476.e11 |
| abstractText | Venous ulcers are the most common type of human chronic nonhealing wounds and are stalled in a constant and excessive inflammatory state. The molecular mechanisms underlying the chronic wound inflammation remain elusive. Moreover, little is known about the role of regulatory RNAs, such as microRNAs, in the pathogenesis of venous ulcers. We found that both microRNA (miR)-34a and miR-34c were upregulated in the wound-edge epidermal keratinocytes of venous ulcers compared with normal wounds or the skin. In keratinocytes, miR-34a and miR-34c promoted inflammatory chemokine and cytokine production. In wounds of wild-type mice, miR-34a-mimic treatment enhanced inflammation and delayed healing. To further explore how miR-34 functions, LGR4 was identified as a direct target mediating the proinflammatory function of miR-34a and miR-34c. Interestingly, impaired wound closure with enhanced inflammation was also observed in Lgr4 knockout mice. Mechanistically, the miR-34-LGR4 axis regulated GSK-3beta-induced p65 serine 468 phosphorylation, changing the activity of the NF-kappaB signaling pathway. Collectively, the miR-34-LGR4 axis was shown to regulate keratinocyte inflammatory response, the deregulation of which may play a pathological role in venous ulcers. |
